Megakaryocytes are a Novel SARS-CoV-2 Infection Target and Risk Factor for Mortality and Multi-Organ Failure

Seth D. Fortmann; Michael J. Patton; Blake F. Frey; Cristiano P. Vieira; Sivani B. Reddy; Forest Huls; Andrew Crouse; Jason Floyd; Ram Prasad; Vidya Sagar Hanumanthu; Sarah Sterrett; Jeremy D. Zucker; Peng Li; Nathan Erdmann; Paul A. Goepfert; Amit Gaggar; Maria B. Grant; Matthew Might

doi:10.1101/2021.08.05.21261552

Megakaryocytes are a Novel SARS-CoV-2 Infection Target and Risk Factor for Mortality and Multi-Organ Failure

Seth D. Fortmann, View ORCID ProfileMichael J. Patton, Blake F. Frey, Cristiano P. Vieira, Sivani B. Reddy, Forest Huls, Andrew Crouse, Jason Floyd, Ram Prasad, Vidya Sagar Hanumanthu, Sarah Sterrett, Jeremy D. Zucker, Peng Li, Nathan Erdmann, Paul A. Goepfert, Amit Gaggar, Maria B. Grant, View ORCID ProfileMatthew Might

doi: https://doi.org/10.1101/2021.08.05.21261552

Seth D. Fortmann

1Medical Scientist Training Program (MSTP), School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA

3Department of Ophthalmology, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Michael J. Patton

1Medical Scientist Training Program (MSTP), School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA

2Hugh Kaul Precision Medicine Institute, University of Alabama at Birmingham, Birmingham, AL, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Michael J. Patton

Blake F. Frey

1Medical Scientist Training Program (MSTP), School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA

4Department of Pathology, University of Alabama at Birmingham, Birmingham, AL

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Cristiano P. Vieira

3Department of Ophthalmology, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Sivani B. Reddy

6Department of Dermatology, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Forest Huls

2Hugh Kaul Precision Medicine Institute, University of Alabama at Birmingham, Birmingham, AL, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Andrew Crouse

2Hugh Kaul Precision Medicine Institute, University of Alabama at Birmingham, Birmingham, AL, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jason Floyd

3Department of Ophthalmology, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Ram Prasad

3Department of Ophthalmology, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Vidya Sagar Hanumanthu

7Department of Medicine and Microbiology, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Sarah Sterrett

8Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jeremy D. Zucker

5Pacific Northwest National Laboratories, Biological Sciences Division, Richland, WA, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Peng Li

9School of Nursing, University of Alabama at Birmingham, Birmingham, AL, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Nathan Erdmann

8Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Paul A. Goepfert

8Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Amit Gaggar

12Department of Medicine, Division of Pulmonary, Allergy and Critical Care, University of Alabama at Birmingham, Birmingham, AL, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Maria B. Grant

3Department of Ophthalmology, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: might@uab.edu

Matthew Might

2Hugh Kaul Precision Medicine Institute, University of Alabama at Birmingham, Birmingham, AL, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Matthew Might
For correspondence: might@uab.edu

Abstract
Full Text
Info/History
Metrics
Supplementary material
Data/Code
Preview PDF

Data Availability

Upon acceptance of the manuscript for publication, an UAB approved subset of de-identified data pertaining to the analyses within the manuscript will be made available.

View the discussion thread.

PreviousNext

Posted August 07, 2021.

Download PDF

Supplementary Material

Data/Code

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Megakaryocytes are a Novel SARS-CoV-2 Infection Target and Risk Factor for Mortality and Multi-Organ Failure

Message Subject (Your Name) has forwarded a page to you from medRxiv

Message Body (Your Name) thought you would like to see this page from the medRxiv website.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Megakaryocytes are a Novel SARS-CoV-2 Infection Target and Risk Factor for Mortality and Multi-Organ Failure

Seth D. Fortmann, Michael J. Patton, Blake F. Frey, Cristiano P. Vieira, Sivani B. Reddy, Forest Huls, Andrew Crouse, Jason Floyd, Ram Prasad, Vidya Sagar Hanumanthu, Sarah Sterrett, Jeremy D. Zucker, Peng Li, Nathan Erdmann, Paul A. Goepfert, Amit Gaggar, Maria B. Grant, Matthew Might

medRxiv 2021.08.05.21261552; doi: https://doi.org/10.1101/2021.08.05.21261552

Share This Article: